OpenAI’s Wild Week: A Custom Chip, 40% of the World’s DRAM, and a $500 Million Bet to Kill the Common Cold
OpenAI designs custom chip, secures DRAM supply, invests $500M in biotech.
“Three things happened to OpenAI last week. The company went from being a model lab to something closer to a vertically integrated empire that wants…”
Why it matters
Weekly Silicon's editorial model scored this 5.95/10 overall, reading it above all as an industry story with cross-cutting implications. Its strongest dimension is regional relevance at 8/10 — direct impact on US technology hubs rather than a purely overseas development — with economic impact close behind at 7/10, pointing to meaningful consequences for capital, capacity, or competition across the industry. The impact is global rather than tied to one US hub, so the thing to watch is how it filters into domestic supply chains and hiring.
Derived from the AI score breakdown below.
AI score breakdown
A composite of 5.95/10 put this story at #7 for Tuesday, June 30, 2026, driven mostly by regional relevance (8/10) and economic impact (7/10).
Composite is the weighted sum of the five dimensions. How scoring works →
Companies in this story
Related stories
- OpenAI Says Its New Chip Outperforms Nvidia’s Blackwell As Nvidia Prepares Earnings Release · 2026-08-27
- How OpenAI let a mob of LLM agents game a test and ransack Hugging Face · 2026-08-27
- OpenAI’s Jalapeño AI chip brings new 'threat' to Nvidia margins as custom silicon gains ground · 2026-08-27
- OpenAI’s 700W Jalapeño ASIC outpaces 1,400W Nvidia flagship GPU — claims up to 1.9x throughput per kilowatt and 3.6x lower latency, co-developed with Broadcom · 2026-08-26
- Should you stare into Sam Altman’s orb before your next date? · 2026-04-18